Sign in

peerhh.bsky.social

@peerhh.bsky.social
7 followers 27 following 7 posts
PostsRepliesMedia
peerhh.bsky.social @peerhh.bsky.social · 27/12/2024
Cool! Never thought about this!
010
peerhh.bsky.social @peerhh.bsky.social · 16/12/2024
Renal denervation after simplicity HTN 3
010
peerhh.bsky.social @peerhh.bsky.social · 16/12/2024
I‘m pretty sure it‘s a continuum. Full dose with best stroke prevention. But eldercare AF taught us, that „tiny dose doac“ still has a huge effect compared to nothing. www.nejm.org/doi/full/10.... Although off-label, there may be some GP wisdom in it.
nejm.org
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM
Implementation of appropriate oral anticoagulant treatment for the prevention of stroke in very elderly patients with atrial fibrillation is challenging because of concerns regarding bleeding. We c...
100
peerhh.bsky.social @peerhh.bsky.social · 14/12/2024
Great educational case! The correlation between FFR and resting gradients is ok, but far from perfect (R values ~0,8). The answer to this case is nicely demonstrated in the paper below: Resting gradients tend to underestimate focal stenosis due to low friction. doi.org/10.1161/CIRC...
061
peerhh.bsky.social @peerhh.bsky.social · 09/12/2024
I really don‘t like the classification in Type 1/2 MI. It doesn‘t differentiate between demand ischemia and acute coronary obstruction! It differentiales between acute atherothombotic event (T1) and all others (T2). So SCAD and Vasospasm are Type 2 MI although thats clearly not demand ischemia.
110
peerhh.bsky.social @peerhh.bsky.social · 06/12/2024
Or maybe an intranasal diuretic will be the gamechanger: newsroom.heart.org/news/nasal-s...
newsroom.heart.org
Nasal spray version of common diuretic has potential to help treat heart failure
Research Highlights: A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal ...
110
peerhh.bsky.social @peerhh.bsky.social · 21/11/2023
Ich finde das Thema Faktor XI-Inhibition schon spannend. Die Hoffnung wäre, dass dadurch selektiv der intrinsische Gerinnungs-Weg gehemmt wird. Theorie: Thrombus im Vorhofohr wird verhindert, nicht aber Hämostase nach Gefässverletzung. Niedrigere Blutungsneigung wäre dann schon ein Mehrwert.
020